Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-24 @ 7:59 PM
NCT ID:
NCT00674804
Brief Summary:
This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:
* Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
* Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
* Identify who informs the patient of their diagnosis..
* Determine patient satisfaction with their diagnostic consult.
* Identify indicators of satisfaction with the diagnostic consultation.
Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.
Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
Detailed Description:
Background:
\- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs.
Objectives:
To distinguish, identify and determine:
* If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed
* Who tells the patient of their condition
* The methods used to inform a patient of their condition
* Prognostic indicators of high satisfaction within the diagnostic consult
Eligibility:
* Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.
* Patient must be 18 years or older and be willing to participate in the study.
Design:
* Primary methodological practice is a self-administered questionnaire.
* Questionnaire to be completed by patient on same day that it is administered at NCI.
Study:
NCT00674804
Study Brief:
Protocol Section:
NCT00674804